Skip to content

Effect of the anti-obesity mixture in metabolic-syndrome : a randomized controlled trial

Effect of the anti-obesity mixture in metabolic-syndrome : a randomized controlled trial - Effect of the anti-obesity mixture in metabolic-syndrome :

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020929
Enrollment
20
Registered
2016-02-08
Start date
2016-01-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic-syndrome

Interventions

Sponsors

GMC Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 20<=age<70 Male and female Out patients 25<=BMI<=30 Healthy adults Nonsmoker Those who are able to obtained consent document

Exclusion criteria

Exclusion criteria: Patient with severe disease Those who cannot avoid drinking the day before study. Those who were participating in other clinical trials within one month Those who may suffer the risk. Those who may not provide enough data.

Design outcomes

Primary

MeasureTime frame
SF8 Body fat Fasting blood sugar level Triglyceride, T-Cho,LDL-Cho,HDL-Cho,TG

Countries

Japan

Contacts

Public ContactMegumi Hayakawa

GMC Ltd. CEO

info@gmc-earth.com0744-47-4395

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026